Isocitrate dehydrogenase (IDH) gene mutation plays a fundamental role in the carbohydrate metabolism, the tumor microenvironment (TME), and was involved in compromising the anti-tumor immune response [4, 5]. The gene discussed is IDH3A; the disease is neoplasm.